MedComm
Unraveling the Metabolic-Cardiovascular Disease Nexus: An Epidemiological Network Analysis Identifies Central Indicators

Cohort study of 4,066 peopleBiomarkers
Independent replication, declared no competing interests
- Machine learning
- Lipid and ceramide metabolism
- Cardiovascular disease
- Abdominal obesity
- Dyslipidemia
- Humans
